NEVVI Medicare utilization intelligence
or

← back

Provider profile

MACRAE, ERIN MD

Medical Oncology · NPI 1033273040 · COLUMBUS, OH

1
Groups
32
Codes · 2024
43,735
Disclosed services

MACRAE, ERIN is a Medical Oncology in COLUMBUS, OH, a member of 1 medical group, who billed 32 distinct codes to Medicare Part B in 2024.

Groups: COLUMBUS ONCOLOGY ASSOCIATES INC (COLUMBUS, OH)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

43,735
disclosed services
32
codes billed to Medicare Part B
Prior year · CY2023 54,687 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J1453 Injection, fosaprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J9190 Injection, fluorouracil, 500 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J3489 Injection, zoledronic acid, 1 mg
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96375 Injection of additional new drug or substance into vein
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96523 Irrigation of implanted venous access drug delivery device
96417 Administration of additional new drug or substance into vein, 1 hour or less
96360 Infusion into a vein for hydration, 31-60 minutes
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96372 Injection of drug or substance under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
96361 Infusion into a vein for hydration, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
36591 Collection of blood sample from implanted device
96374 Injection of drug or substance into vein
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
38222 Biopsy and aspiration of bone marrow sample for diagnosis
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.